IMV Inc.
IMV
Peringkat dalam Saham
#35144
IMV Inc. is a clinical-stage biotechnology company dedicated to the development... IMV Inc. is a clinical-stage biotechnology company dedicated to the development of innovative immunotherapies. The company utilizes its proprietary DPX immune-educating technology platform to create a portfolio of treatments for various solid and hematological cancers. Its leading investigational drug, maveropepimut-S, is a DPX-based immunotherapy designed to target cancer cells that express survivin. Maveropepimut-S is currently undergoing Phase II clinical trials for diffuse large B-cell lymphoma, ovarian cancer, and specific bladder, liver, and microsatellite instability-high tumors, with Phase I trials also active for breast cancer. Beyond its primary candidate, IMV is also advancing DPX-SurMAGE, which is in Phase I clinical trials for bladder cancer, and is developing DPX-COVID-19 and DPX-RSV to address infectious diseases. Originally founded in 2000 as Immunovaccine Inc., the company adopted the name IMV Inc. in May 2018 and operates from its headquarters in Dartmouth, Canada.
Harga Saham
$0.82959892
Terakhir disinkronkan: 2023-05-23
Kapitalisasi Pasar
$4.16M
Perubahan (1 hari)
-0.04%
Perubahan (1 tahun)
82,959,792.06%
Negara
CA
Perdagangan IMV Inc. (IMV)
Kategori
Healthcare
Riwayat pemecahan saham untuk IMV Inc. (IMV)
Saham IMV Inc. (simbol: IMV) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Oct 21, 2026.
Satu lembar saham IMV yang dibeli sebelum Oct 21, 2026 sekarang setara dengan 0 lembar saham IMV.
Pemecahan saham terbaru terjadi pada Oct 21, 2026.
Satu lembar saham IMV yang dibeli sebelum Oct 21, 2026 sekarang setara dengan 0 lembar saham IMV.
Daftar pemecahan saham
| Tahun | Pemecahan | Kelipatan | Kelipatan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tanggal yang disediakan. | |||
Pemecahan saham untuk perusahaan sejenis atau pesaing
| Perusahaan | Jumlah pemecahan saham | Kelipatan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
